Related Experiment Videos
The problem of cycloplegia in the pediatric age group: a combination formula for refraction
Insights
Minimal concentrations of cycloplegic agents reduce toxicity and discomfort during pediatric eye exams. A combination of Cyclogyl, Mydriacil, and phenylephrine provides effective cycloplegia with fewer side effects.
Area of Science:
- Ophthalmology
- Pediatric Medicine
- Pharmacology
Background:
- Cycloplegic refraction and indirect ophthalmoscopy are crucial for pediatric eye evaluations.
- Current cycloplegic agents present risks of toxicity and patient discomfort, with literature often showing conflicting efficacy and side effect data.
- Agent concentration is directly related to both efficacy and toxicity/discomfort.
Purpose of the Study:
- To evaluate a combination of cycloplegic agents at minimal effective concentrations for pediatric eye examinations.
- To determine if this combination minimizes discomfort and toxicity while maintaining efficacy.
Main Methods:
- A combination of 1.3% cyclopentolate (Cyclogyl), 0.167% tropicamide (Mydriacil), and 1.6% phenylephrine was administered.
- The study assessed efficacy for cycloplegic refraction and indirect ophthalmoscopy, onset/duration of action, reliability in dark irides, and side effect profiles.
Main Results:
- The combination achieved effective cycloplegia for both refraction and ophthalmoscopy.
- The formulation demonstrated rapid onset and short duration of action.
- It proved reliable in patients with dark irides and was administered in a single visit.
- No significant side effects were observed in the series.
Conclusions:
- Using minimal effective concentrations of cycloplegic agents is key to balancing efficacy with reduced patient discomfort and toxicity.
- The specific combination of 1.3% Cyclogyl, 0.167% Mydriacil, and 1.6% phenylephrine offers an effective, well-tolerated option for pediatric eye exams.
Abstract:
Cycloplegic refraction and indirect ophthalmoscopy are essential to evaluation of the pediatric patient. Unfortunately, along with this practice occur the attendant risks of toxicity and the unpleasantness of instillation. The literature that documents the development of cycloplegic agents is often contradictory regarding efficacy and side effects. It is presented for perspective. We have found that efficacy and discomfort are inseparable; however, as with efficacy and toxicity they are directly related to the concentration used. The case is therefore made to use each agent in its minimal effective concentration and thereby minimize both discomfort and toxicity. Our combination of 1.3% cyclogyl, .167% mydriacil, and 1.6% phenylephrine accomplishes effective cycloplegia for refraction and indirect ophthalmoscopy, has a rapid onset and short duration, works reliably in dark irides, is accomplished in a single encounter with the patient, and exhibits none of the side effects of the individual agents in our series.